Literature DB >> 9871107

Evidence for Clostridium perfringens enterotoxin (CPE) inducing a mitogenic and cytokine response in vitro and a cytokine response in vivo.

F M Wallace1, A S Mach, A M Keller, J A Lindsay.   

Abstract

We investigated some immunogenic properties of Clostridium perfringens enterotoxin (CPE) in vitro using murine J774A macrophages (MPhi) and in vivo using Swiss Webster (SW) mice. CPE was a potent mitogen in vitro, where cell proliferation increased with CPE concentration. CPE was nonmitogenic when MPhi were concurrently incubated with CPE and interferon gamma (IFN-gamma). MPhi incubated in the presence of CPE induced the synthesis of interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-alpha) and interferon-gamma (IFN-gamma), but not interleukin-2 (IL-2). In vivo, CPE induced a pro-inflammatory cytokine response with striking production of IFN-gamma, IL-1, and IL-6. Regardless of route of CPE entry, serum cytokine levels generally peaked within 1 h of administration and were maintained for 4-8 h. Although CPE engenders an intense immune response during toxicosis, the toxin does not appear to be a superantigen. Death from CPE-induced shock appears to result from various interrelating immunological mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9871107     DOI: 10.1007/s002849900410

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  10 in total

1.  Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin.

Authors:  Babak Litkouhi; Joseph Kwong; Chun-Min Lo; James G Smedley; Bruce A McClane; Margarita Aponte; Zhijian Gao; Jennifer L Sarno; Jennifer Hinners; William R Welch; Ross S Berkowitz; Samuel C Mok; Elizabeth I O Garner
Journal:  Neoplasia       Date:  2007-04       Impact factor: 5.715

2.  Mitogenic effect contributes to increased virulence of Streptococcus suis sequence type 7 to cause streptococcal toxic shock-like syndrome.

Authors:  H Zheng; C Ye; M Segura; M Gottschalk; J Xu
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

3.  Cecal infusion of butyrate increases intestinal cell proliferation in piglets.

Authors:  C Lawrence Kien; Ruth Blauwiekel; Janice Y Bunn; Thomas L Jetton; Wendy L Frankel; Jens J Holst
Journal:  J Nutr       Date:  2007-04       Impact factor: 4.798

4.  C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin.

Authors:  Zhijian Gao; Xiaoyin Xu; Bruce McClane; Qing Zeng; Babak Litkouhi; William R Welch; Ross S Berkowitz; Samuel C Mok; Elizabeth I O Garner
Journal:  Clin Cancer Res       Date:  2010-12-01       Impact factor: 12.531

Review 5.  Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers.

Authors:  Yosuke Hashimoto; Kiyohito Yagi; Masuo Kondoh
Journal:  Pflugers Arch       Date:  2016-09-15       Impact factor: 3.657

6.  Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4.

Authors:  Scott L Kominsky; Mustafa Vali; Dorian Korz; Theodore G Gabig; Sigmund A Weitzman; Pedram Argani; Saraswati Sukumar
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

7.  Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4.

Authors:  Yanlong Jiang; Qingke Kong; Kenneth L Roland; Amanda Wolf; Roy Curtiss
Journal:  Pathog Dis       Date:  2014-03-11       Impact factor: 3.166

Review 8.  Specificity of interaction between clostridium perfringens enterotoxin and claudin-family tight junction proteins.

Authors:  Leslie A Mitchell; Michael Koval
Journal:  Toxins (Basel)       Date:  2010-06-24       Impact factor: 4.546

9.  Use of Clostridium perfringens Enterotoxin and the Enterotoxin Receptor-Binding Domain (C-CPE) for Cancer Treatment: Opportunities and Challenges.

Authors:  Zhijian Gao; Bruce A McClane
Journal:  J Toxicol       Date:  2011-09-15

10.  Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy.

Authors:  A D Santin; F Zhan; S Cane'; S Bellone; M Palmieri; M Thomas; A Burnett; J J Roman; M J Cannon; J Shaughnessy; S Pecorelli
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.